SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-010966
Filing Date
2017-06-08
Accepted
2017-06-08 16:23:55
Documents
7
Period of Report
2017-06-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tlcc20170608_8k.htm 8-K 59184
2 EXHIBIT 10.165 ex10-165.htm EX-10.165 88459
3 EXHIBIT 10.166 ex10-166.htm EX-10.166 40824
4 EXHIBIT 10.167 ex10-167.htm EX-10.167 127016
5 EXHIBIT 10.168 ex10-168.htm EX-10.168 131004
6 EXHIBIT 10.169 ex10-169.htm EX-10.169 237198
7 EXHIBIT 10.170 ex10-170.htm EX-10.170 42561
  Complete submission text file 0001437749-17-010966.txt   727615
Mailing Address 632 BROADWAY SUITE 201 NEW YORK NY 10012
Business Address 632 BROADWAY SUITE 201 NEW YORK NY 10012 (212) 651-8500
TWINLAB CONSOLIDATED HOLDINGS, INC. (Filer) CIK: 0001590695 (see all company filings)

IRS No.: 463951742 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55181 | Film No.: 17900482
SIC: 2833 Medicinal Chemicals & Botanical Products